tirzepatide compound banned 🚨 Important Update on Compounded 🚨, As of March 19th, the FDA has officially compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA Drug Recalls and Warnings:

GLP-1 agonists in type 1 diabetes mellitus (PubMed) Storgaard H, et al

Patients natural figure was enhanced, showing slimmer waist, flattened stomach, and tightened skin

Tell your healthcare provider if you experience frequent dizziness

Real-world weight loss with GLP-1s

The manufacturer has already developed a new patch-type diabetes treatment (egg microneedle) to overcome the limitations of existing dissolvable microneedles, exhibiting potential for successful GLP-1 patch development

Additionally, the patients with MAFLD had a 63% higher risk of having severe acute pancreatitis compared with patients with acute pancreatitis who did not have MAFLD